Innovative New Level2 Digital Health Therapy Resulted in Better Health for People with Type 2 Diabetes - Seite 2
Initial studies show that sudden changes in blood sugar levels among people with type 2 diabetes may indicate potential COVID-19 infections. Closely monitoring this metric among Level2 participants and supporting people at greater risk for COVID-19 complications, Level2 has demonstrated the ability to predict potential COVID-19 infections and help encourage access to needed medical care earlier. Type 2 diabetes may be a risk factor associated with worse outcomes related to COVID-19.3 However, people with type 2 diabetes whose blood sugar is stable may experience fewer medical complications and greater likelihood of recovery from COVID-19.4
Level2 is part of UnitedHealth Group’s industry-leading focus on integrating human support with advanced data analytics, including from real-time sources such as digital health technologies, to help improve and personalize therapies. UnitedHealth Group initiatives in clinical research and science are focused on a range of health conditions and most recently COVID-19, including collaborations with leading academic institutions. More details are available at unitedinresearch.com.
Through Level2, the combination of wearable technology, clinical coaching, lifestyle changes and incentives* — all offered at no additional cost to eligible UnitedHealthcare members who enroll — is designed to help empower people with type 2 diabetes to become healthier and potentially achieve remission. This is accomplished by helping participants use the latest scientifically proven techniques and personalized support to understand and more effectively stabilize blood sugar levels.
More than 230,000 UnitedHealthcare employer-sponsored, fully insured health plan participants in 27 states and Washington D.C. are now eligible for Level2. Participants enrolled in some employer-sponsored health plans may earn financial incentives, including cash or gift cards, by taking actions such as consistently wearing a CGM; completing post-meal walks; interacting with an assigned coach; and following personalized recommendations*.
Lesen Sie auch
This multifaceted therapy is being expanded on a pilot basis to select plan participants enrolled in eligible employer-sponsored, fully insured health plans in the following markets: Arizona, Arkansas, Colorado, Connecticut, Florida, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Michigan, Mississippi, Missouri, Nebraska, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Washington, D.C., West Virginia, and Wisconsin.